tiprankstipranks
CARGO Therapeutics, Inc. (CRGX)
NASDAQ:CRGX
US Market
Holding CRGX?
Track your performance easily

CARGO Therapeutics, Inc. (CRGX) Income Statement

26 Followers

CARGO Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), CARGO Therapeutics, Inc.'s total revenue was $568.00K, an increase of Infinity% from the same quarter last year. In Q3, CARGO Therapeutics, Inc.'s net income was $-41.91M. See CARGO Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
$ 578.00K$ 290.00K-
Cost of Revenue
---
Gross Profit
$ 578.00K$ 290.00K-
Operating Expense
$ 172.19M$ 96.71M$ 34.77M
Operating Income
$ -172.19M$ -96.71M$ -34.77M
Net Non Operating Interest Income Expense
$ 15.39M$ -1.60M$ -4.94M
Other Income Expense
$ 6.02M$ 167.00K$ 1.24M
Pretax Income
$ -162.49M$ -98.15M$ -40.95M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -154.14M$ -98.15M$ -40.95M
Basic EPS
$ 75.99$ -16.53$ -104.40
Diluted EPS
$ 75.99$ -16.53$ -104.40
Basic Average Shares
$ 153.74M$ 5.94M$ 392.27K
Diluted Average Shares
$ 153.74M$ 5.94M$ 392.27K
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 172.19M$ 96.71M$ 34.77M
Net Income From Continuing And Discontinued Operation
$ -154.14M$ -98.15M$ -40.95M
Normalized Income
$ -110.39M--
Interest Expense
---
EBIT
$ -154.14M$ -87.76M-
EBITDA
$ -145.03M$ -84.06M-
Currency in USD

CARGO Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis